个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

A protocol of Chinese expert consensuses for the management of health risk in the general public

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE ◇ SSCI

作者：
Wang Danni[1] ; He Qiangsheng[1] ; Xia Bin[1] ; Zheng Jie[2,3,4] ; Cao Wangnan[5] ; Su Shaochen[6] ; Hu Fulan[7] ; Li Jiang[8,9] ; Zhang Yuelun[10] ; Ren Zhengjia[11] ; Li Xue[12,13,14] ; Wu Xinyin[15] ; Huang Yafang[16] ; Tang Yongjiang[17] ; Wei Fuxin[18] ; Zou Huachun[19] ; Jiang Huaili[20] ; Huang Junjie[21] ; Meng Wenbo[22] ; Bai Ming[23] ; Yang Kehu[24,25,26] ; Yuan Jinqiu[1] ;
机构： [1]Department of Epidemiology and Biostatistics, Clinical Big Data Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. [2]Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [3]Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [4]MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom. [5]Department of Social Medicine and Health Education, School of Public Health, Peking University, Beijing, China. [6]Healthy Examination & Management Center, The First Hospital of Lanzhou University, Lanzhou, China. [7]Department of Epidemiology and Biostatistics, School of Public Health, Shenzhen University Health Science Center, Shenzhen, China. [8]Office for Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. [9]Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement, Beijing, China. [10]Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. [11]Department of Clinical Psychology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China. [12]Center for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. [13]Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong, China. [14]Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China. [15]Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China. [16]School of General Practice and Continuing Education, Capital Medical University, Beijing, China. [17]Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China. [18]Department of Orthopaedic Surgery, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China. [19]Department of Epidemiology, School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China. [20]Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China. [21]Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. [22]Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China. [23]The Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China. [24]Health Technology Assessment Center, Evidence Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China. [25]Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China. [26]Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, China.
出处：
DOI： 10.3389/fpubh.2023.1225053
ISSN：

关键词： non-communicable diseases (NCDs) primary prevention risk factors risk management protocols & guidelines

摘要：
Non-communicable diseases (NCDs) represent the leading cause of mortality and disability worldwide. Robust evidence has demonstrated that modifiable lifestyle factors such as unhealthy diet, smoking, alcohol consumption and physical inactivity are the primary causes of NCDs. Although a series of guidelines for the management of NCDs have been published in China, these guidelines mainly focus on clinical practice targeting clinicians rather than the general population, and the evidence for NCD prevention based on modifiable lifestyle factors has been disorganized. Therefore, comprehensive and evidence-based guidance for the risk management of major NCDs for the general Chinese population is urgently needed. To achieve this overarching aim, we plan to develop a series of expert consensuses covering 15 major NCDs on health risk management for the general Chinese population. The objectives of these consensuses are (1) to identify and recommend suitable risk assessment methods for the Chinese population; and (2) to make recommendations for the prevention of major NCDs by integrating the current best evidence and experts' opinions.For each expert consensus, we will establish a consensus working group comprising 40-50 members. Consensus questions will be formulated by integrating literature reviews, expert opinions, and an online survey. Systematic reviews will be considered as the primary evidence sources. We will conduct new systematic reviews if there are no eligible systematic reviews, the methodological quality is low, or the existing systematic reviews have been published for more than 3 years. We will evaluate the quality of evidence and make recommendations according to the GRADE approach. The consensuses will be reported according to the Reporting Items for Practice Guidelines in Healthcare (RIGHT).Copyright © 2023 Wang, He, Xia, Zheng, Cao, Su, Hu, Li, Zhang, Ren, Li, Wu, Huang, Tang, Wei, Zou, Jiang, Huang, Meng, Bai, Yang and Yuan.

基金：
This work was supported by the Natural Science Foundation of China (grant numbers 82003524, 82103913, 82003408).
语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 3 区 医学
小类 | 3 区 公共卫生、环境卫生与职业卫生
最新[2023]版：
大类 | 3 区 医学
小类 | 3 区 公共卫生、环境卫生与职业卫生
JCR分区：
出版当年[2023]版：
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
最新[2023]版：
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者：
第一作者机构： [1]Department of Epidemiology and Biostatistics, Clinical Big Data Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
通讯作者：
通讯机构： [24]Health Technology Assessment Center, Evidence Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China. [25]Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China. [26]Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, China.
推荐引用方式(GB/T 7714)：
Wang Danni,He Qiangsheng,Xia Bin,et al.A protocol of Chinese expert consensuses for the management of health risk in the general public[J].FRONTIERS IN PUBLIC HEALTH.2023,11:doi:10.3389/fpubh.2023.1225053.
APA：
Wang Danni,He Qiangsheng,Xia Bin,Zheng Jie,Cao Wangnan...&Yuan Jinqiu.(2023).A protocol of Chinese expert consensuses for the management of health risk in the general public.FRONTIERS IN PUBLIC HEALTH,11,
MLA：
Wang Danni,et al."A protocol of Chinese expert consensuses for the management of health risk in the general public".FRONTIERS IN PUBLIC HEALTH 11.(2023)

相关文献

[1]Prostate cancer in Asia: A collaborative report(Open Access) [2]An opportunity for primary prevention research in psychotic disorders. [3]Cystic echinococcoses in Mongolia: molecular identification, serology and risk factors [4]规范化培训阶段住院医师的医疗风险管理 [5]Updated incidence rates and risk factors of esophageal cancer in Nan'ao Island, a coastal high-risk area in southern China. [6]The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T-cell lymphoma [7]Analysis of risk factors for pulmonary infection in patients with minimally invasive esophagectomy [8]Incidence and risk factors of VTE in lung cancer: a meta-analysis [9]Postoperative cognitive dysfunction-current research progress [10]Risk and Prognostic Factors for Different Organ Metastasis in Primary Osteosarcoma: A Large Population-Based Analysis.

资源点击量：43377 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号